Bayer AG (BAYZF.PK)

BAYZF.PK on OTC Markets Group

143.25USD
17 Apr 2015
Change (% chg)

$-5.20 (-3.50%)
Prev Close
$148.45
Open
$144.32
Day's High
$144.32
Day's Low
$143.25
Volume
440
Avg. Vol
1,134
52-wk High
$155.97
52-wk Low
$125.60

BAYZF.PK

Chart for BAYZF.PK

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €110,397.50
Shares Outstanding(Mil.): 826.95
Dividend: 2.25
Yield (%): 1.69

Financials

  BAYZF.PK Industry Sector
P/E (TTM): 32.22 40.59 41.17
EPS (TTM): 4.14 -- --
ROI: 7.50 16.74 16.08
ROE: 16.78 17.27 16.92
Search Stocks

BRIEF-Bayer to early redeem 1.3 bln eur bond issued in 2005

* Says first opportunity to repay the subordinated bond with a 5 pct coupon and a 100-year maturity issued in 2005 arises on July 29 Source text: http://bit.ly/1FJg8ro Further company coverage:

15 Apr 2015

BRIEF-Bayer to launch two late-stage trials of Copanlisib

* Says to commence two Copanlisib Phase III studies on patients with indolent non-hodgkin lymphoma Further company coverage:

14 Apr 2015

BRIEF-Bayer says China study confirms Eylea improves vision

* Says new phase 3 study in china confirms vision improvement for patients with wet age-related macular degeneration when receiving aflibercept solution (Eylea) for intravitreal injection

01 Apr 2015

BRIEF-Bayer issues 1.3 bln eur of 60-year hybrid bonds

* Bonds have a final maturity of 60 years and a coupon of 2.375 percent Source text: http://www.press.bayer.com/baynews/baynews.nsf/id/Bayer-issues-EUR-13-billion-in-hybrid-capital? Further company coverage:

30 Mar 2015

New Issue-Bayer Aktiengesellschaft prices 1.3 bln euro 2075 bond

where assigned, and hit the newskey (F9 on Reuters terminals)

30 Mar 2015

BRIEF-Bayer receives approval of Gadovist injection in Japan

* Receives approval for Gadovist (gadobutrol) injection in Japan Further company coverage:

26 Mar 2015

Bayer weighing options for consumer garden products

FRANKFURT - Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers.

20 Mar 2015

Bayer weighing options for consumer garden products

FRANKFURT - Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers.

20 Mar 2015

UPDATE 1-Bayer weighing options for consumer garden products

* Bayer preparing sale of consumer home and garden unit-sources

20 Mar 2015

Bayer weighing options for consumer house and garden products

FRANKFURT, March 20 - Germany's largest drugmaker Bayer said it was considering strategic options for the consumer products part of its Environmental Science business, which makes about 220 million euros ($236 million) in sales from pesticides, pest control products and fertilisers.

20 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks